Drawing for MANNA TREE HEALTH

USPTO serial 88650245

MANNA TREE HEALTH

Reviewed by CopyMark Law Group

Reg. 6078655Status 700Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
CLARK, ANDREW T
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MANNA TREE HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel P. Mullarkey

Daniel P. Mullarkey Polsinelli PCPO BOX 140310Kansas City, MO 64114-0310UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036Charitable foundation services, namely, providing fundraising activities and investment management services to support medical education and research and procedures for those in needACTIVEOct 10, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 16, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 18, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 18, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 4, 2020ALIEASSIGNED TO LIE—
Jan 30, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2020GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 22, 2020GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 22, 2020EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Jan 22, 2020CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 15, 2020DOCKASSIGNED TO EXAMINER—
Oct 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance